Skip to main content
Susan Buchbinder, MD, Internal Medicine, San Francisco, CA

SusanPamelaBuchbinderMD

Internal Medicine San Francisco, CA

Physician

Dr. Buchbinder is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Buchbinder's full profile

Already have an account?

  • Office

    1001 Potrero Avenue
    RM 5H22
    San Francisco, CA 94110
    Phone+1 415-206-8317
    Fax+1 415-476-8965

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1985 - 1988
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1985

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1987 - 2027
  • American Board of Internal Medicine Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults  
    Michael S Saag, Melanie A Thompson, Constance A Benson, Susan P Buchbinder, Joseph J Eron, Donna M Jacobsen, JAMA

Press Mentions

  • HIV Vaccine Research Update with Dr. Dieffenbach from CROI 2023
    HIV Vaccine Research Update with Dr. Dieffenbach from CROI 2023February 22nd, 2023
  • Why Inventing a Vaccine for AIDS Is Tougher Than for COVID
    Why Inventing a Vaccine for AIDS Is Tougher Than for COVIDJanuary 26th, 2023
  • A Promising HIV Vaccine Just Failed an Important Clinical Trial
    A Promising HIV Vaccine Just Failed an Important Clinical TrialJanuary 20th, 2023
  • Join now to see all

Grant Support

  • Prevention Umbrella For MSM In The AmericasNational Institute Of Allergy And Infectious Diseases2009–2012
  • SAN Francisco Vaccine And Prevention UnitNational Institute Of Allergy And Infectious Diseases2007–2012
  • SAN Francisco HIV Vaccine Clinical Trails UnitNational Institute Of Allergy And Infectious Diseases2000–2006
  • Phase II Extended Safety Study Of Tenofovir Disoproxil Fumarate (TDF) Among HNational Center For Research Resources2005
  • HVTN Protocol 056, Version 1: A Phase I Clinical Trial To Evaluate The Safety AnNational Center For Research Resources2005
  • HVTN Protocol 042/Anrs Vac019, Version 1: A Phase I/II Clinical TrialNational Center For Research Resources2005
  • HVTN 057: A Phase I Clinical Trial To Evaluate The Safety Of A Multiclade RECNational Center For Research Resources2005
  • HVTN 052: HIV-1 DNA Plasmid Vaccine At 2 Different Dosings In Hiv-1-Uninfected ANational Center For Research Resources2005
  • HVTN 050/Merck 018safety, Tolerability, And Immunogenicity Of Mrkad5 HIV-1 GAG VNational Center For Research Resources2005
  • Safety, Tolerability, And Immunogenicity Of Mrkad5 HIV-1 GAG VaccineNational Center For Research Resources2004
  • HIV-1 Pga2/Js2 Plasmid DNA Vaccine In HIV-1 Uninfected AdultsNational Center For Research Resources2004
  • HIV-1 DNA Plasmid Vaccine At 2 Different Dosings In Hiv-1-Uninfected AdultsNational Center For Research Resources2004
  • Trial Of Live (PRIVATE) Recombinant Canarypox Alva-Hiv Vcp205 In HIVNational Center For Research Resources1998–2000